182 related articles for article (PubMed ID: 16517838)
1. Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: pharmacokinetic, pharmacodynamic, and toxicologic effects.
Halpern WG; Lappin P; Zanardi T; Cai W; Corcoran M; Zhong J; Baker KP
Toxicol Sci; 2006 Jun; 91(2):586-99. PubMed ID: 16517838
[TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator.
Baker KP; Edwards BM; Main SH; Choi GH; Wager RE; Halpern WG; Lappin PB; Riccobene T; Abramian D; Sekut L; Sturm B; Poortman C; Minter RR; Dobson CL; Williams E; Carmen S; Smith R; Roschke V; Hilbert DM; Vaughan TJ; Albert VR
Arthritis Rheum; 2003 Nov; 48(11):3253-65. PubMed ID: 14613291
[TBL] [Abstract][Full Text] [Related]
3. Developmental and peri-postnatal study in cynomolgus monkeys with belimumab, a monoclonal antibody directed against B-lymphocyte stimulator.
Auyeung-Kim DJ; Devalaraja MN; Migone TS; Cai W; Chellman GJ
Reprod Toxicol; 2009 Dec; 28(4):443-55. PubMed ID: 19631735
[TBL] [Abstract][Full Text] [Related]
4. Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys.
Schröder C; Azimzadeh AM; Wu G; Price JO; Atkinson JB; Pierson RN
Transpl Immunol; 2003; 12(1):19-28. PubMed ID: 14551029
[TBL] [Abstract][Full Text] [Related]
5. Chronic administration of belatacept, a T-cell costimulatory signal blocker, in cynomolgus monkeys.
Haggerty HG; Proctor SJ
Toxicol Sci; 2012 May; 127(1):159-68. PubMed ID: 22331490
[TBL] [Abstract][Full Text] [Related]
6. A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys.
Vugmeyster Y; Seshasayee D; Chang W; Storn A; Howell K; Sa S; Nelson T; Martin F; Grewal I; Gilkerson E; Wu B; Thompson J; Ehrenfels BN; Ren S; Song A; Gelzleichter TR; Danilenko DM
Am J Pathol; 2006 Feb; 168(2):476-89. PubMed ID: 16436662
[TBL] [Abstract][Full Text] [Related]
7. Belimumab: anti-BLyS human monoclonal antibody, anti-BLyS monoclonal antibody, BmAb, human monoclonal antibody to B-lymphocyte stimulator.
Drugs R D; 2008; 9(3):197-202. PubMed ID: 18457473
[TBL] [Abstract][Full Text] [Related]
8. Belimumab--an anti-BLyS human monoclonal antibody for rheumatoid arthritis.
Jin X; Ding C
Expert Opin Biol Ther; 2013 Feb; 13(2):315-22. PubMed ID: 23268610
[TBL] [Abstract][Full Text] [Related]
9. Belimumab: a BLyS-specific inhibitor for systemic lupus erythematosus.
Wiglesworth AK; Ennis KM; Kockler DR
Ann Pharmacother; 2010 Dec; 44(12):1955-61. PubMed ID: 21081710
[TBL] [Abstract][Full Text] [Related]
10. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C
J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010
[TBL] [Abstract][Full Text] [Related]
11. Effect of anti-CD20 monoclonal antibody, Rituxan, on cynomolgus monkey and human B cells in a whole blood matrix.
Vugmeyster Y; Howell K; Bakshl A; Flores C; Canova-Davis E
Cytometry A; 2003 Apr; 52(2):101-9. PubMed ID: 12655653
[TBL] [Abstract][Full Text] [Related]
12. Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus.
Furie R; Stohl W; Ginzler EM; Becker M; Mishra N; Chatham W; Merrill JT; Weinstein A; McCune WJ; Zhong J; Cai W; Freimuth W;
Arthritis Res Ther; 2008; 10(5):R109. PubMed ID: 18786258
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and immunological effects of exogenously administered recombinant human B lymphocyte stimulator (BLyS) in mice.
Parry TJ; Riccobene TA; Strawn SJ; Williams R; Daoud R; Carrell J; Sosnovtseva S; Miceli RC; Poortman CM; Sekut L; Li Y; Fikes J; Sung C
J Pharmacol Exp Ther; 2001 Feb; 296(2):396-404. PubMed ID: 11160623
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse.
Cambridge G; Stohl W; Leandro MJ; Migone TS; Hilbert DM; Edwards JC
Arthritis Rheum; 2006 Mar; 54(3):723-32. PubMed ID: 16508933
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of human B lymphocyte stimulator blocking monoclonal antibody.
Zhuang W; Zhang J; Pei L; Fang S; Liu H; Wang R; Su Y
Mol Immunol; 2016 Sep; 77():141-7. PubMed ID: 27505709
[TBL] [Abstract][Full Text] [Related]
16. Fully human anti-BAFF inhibitory monoclonal antibody tabalumab does not adversely affect T-dependent antibody responses in cynomolgus monkey (Macaca fasicularis): A summary of three pre-clinical immunotoxicology evaluations.
Komocsar WJ; Blackbourne JL; Halstead CA; Winstead CJ; Wierda D
J Immunotoxicol; 2016; 13(1):7-19. PubMed ID: 25585959
[TBL] [Abstract][Full Text] [Related]
17. An Enhanced Pre- and Postnatal Development Study in Cynomolgus Monkeys with Tabalumab: A Human IgG4 Monoclonal Antibody.
Breslin WJ; Hilbish KG; Martin JA; Halstead CA; Newcomb DL; Chellman GJ
Birth Defects Res B Dev Reprod Toxicol; 2015 Jun; 104(3):100-16. PubMed ID: 26195230
[TBL] [Abstract][Full Text] [Related]
18. [Research progress on B cell surface molecules targeted therapy in rheumatoid arthritis].
Di W; Chang Y; Wu YJ; Wei W
Sheng Li Ke Xue Jin Zhan; 2011 Jun; 42(3):175-80. PubMed ID: 21932514
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Nickel Subsulfide (CAS No. 12035-72-2) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Jul; 453():1-365. PubMed ID: 12594522
[TBL] [Abstract][Full Text] [Related]
20. Differential in vivo effects of rituximab on two B-cell subsets in cynomolgus monkeys.
Vugmeyster Y; Howell K; McKeever K; Combs D; Canova-Davis E
Int Immunopharmacol; 2003 Oct; 3(10-11):1477-81. PubMed ID: 12946444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
